The UW Health Nursing Excellence Awards were announced at a special ceremony this week, one of the highlights of Nursing Week 2019. Musculoskeletal Section nurse Erica Timm, BSN, RN, won the top award for Clinical Nursing Excellence. Timm was selected from a large field of nominees for this prestigious award. Department of Radiology nominees Marcia Foltz, Norzin Lhamo and Kelly Wergin were also recognized for the valued contributions to patient care.
Read the full story here. This National Nurses Week, we would like to recognize all Department of Radiology nursing staff for their hard work and commitment to patients!
Sameer Raniga, MD, FACR, recently visited the Department of Radiology MSK Section the UW-Madison for the Lee Rogers fellowship. Dr. Raniga is currently a full-time attending radiologist at the University Hospital Muscat, Oman, and is a faculty and trainer in the radiology training program of Oman. He has made presentations at RSNA, ARRS, and ESR, many of which have won awards. Dr. Raniga has also delivered scientific presentations at national and international conferences, including RSNA, ARRS, and ESR.
The Lee Rogers fellowship in radiology journalism is presented to an academic radiologist who works outside of North America by the Roentgen Fund. This gives the selected radiologist an opportunity to improve their radiology journalism skills with hands-on experience working with the American Journal of Roentgenology (AJR) and its editors. Dr. Donna Blankenbaker, Musculoskeletal Section editor of the MSK at the AJR, was Dr. Raniga’s first choice with whom to work. She has published a substantial amount of peer-reviewed literature on MSK-related topics, and is considered a world-renowned authority in MSK imaging.
Dr. Blankenbaker prepared a rigorous schedule for Dr. Raniga’s visit to provide him with the opportunity to interact with Dr. Blankenbaker and her co-faculties, fellows, as well as residents. Dr. Raniga also shadowed her performing imaging-guided procedures, teaching-mentoring radiology residents, and MSK fellows. She enrolled him in the MSK reviewers pool of AJR. Dr. Raniga reviewed three articles of AJR during the course of his one-week visit. Dr. Blankenbaker invited him to deliver a lecture to the UW radiology residents as a visiting professor. His lecture was titled “CT in Pelvic Trauma – Back on the Basics.”
“Working with Dr. Blankenbaker and how she maintains a clinical-academic time balance was the highlight of my fellowship,” Dr. Raniga said. “I think I learned a lot during my visit, I accomplished more than my expectations, and I earned Dr. Blankenbaker as my mentor. I will cherish this experience for the rest of my life.”
The Department of Radiology’s Neuroradiology Section had a great showing at the 57th Annual American Society of Neuroradiology Meeting in Boston! Not only did our incredible faculty present three invited talks and five abstracts - they also mentored trainee radiologists to present their medical scholarship as well! Our dedicated fellow, resident, medical student, and undergraduate trainees presented a total of five abstracts and two posters during the meeting. The educational exhibit entitled "Unintended Consequences: Review of New Artifacts Introduced by Iterative Reconstruction CT Metal Artifact Reduction in Spine Imaging," authored by medical student Daniel Wayer, residents Dr. Brad Otto and Dr. Nathan Kim, and Radiology Department mentors Dr. Allison Grayev and Dr. Anthony Kuner, earned the ASNR Certificate of Merit. Dr. Tabby Kennedy, the ASNR Chair of Neuroradiology Fellowship Directors Committee, organized the hugely successful inaugural Fellowship Reunion Night that brought together alumni from fellowship programs all over the country. Of course, there was a great turnout for UW alumni at this event. On Wisconsin! Follow us on Twitter @UWiscNeuroRad.
Zuhura Nkrumbih, MD, a visiting professor from Tanzania, Africa, recently visited the Breast Imaging Section within the Department of Radiology at UW–Madison for the Derek Harwood Nash International Fellowship. She was among the first class of Radiologist residents at Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam, Tanzania, Africa, which started in 2007. Dr. Nkrumbih is now one of the few Radiologists practicing at MUHAS. She is also a University lecturer in her department, who is involved in teaching and supervising both undergraduate and post-graduate students. Tanzania has a population of over 57 million people, with a total of five specialized hospitals. This includes village dispensaries, district hospitals, regional hospitals, zone referral hospital, and national specialized hospital.
The Derek Harwood fellowship is a huge honor that is awarded from the Radiological Society of North America (RSNA), to individuals who reside outside the United States or Canada. The ultimate goal of this fellowship is to provide international faculty members with the opportunity to gain more knowledge about their specialty through in person experiences. The appointed fellow has to select amongst a given roster of host institutions with a focus on their field of interest. Dr. Nkrumbih chose the Breast Imaging section at UW-Madison due to her passion for women and imaging. This interest was acquired during her residency studies, as well as her dissertation work on Obstetrics.
In Tanzania, breast cancer is the second leading cancer mortality amongst women, followed by cervical cancer. There is an 82% predicted increase in number of new breast cancer patients diagnosed in Tanzania by 2030 (Source: http://globocan.iarc.fr). Dr. Nkrumbih’s ultimate objective is to learn as much as possible about the equipment, and the experiences from Radiologists around the world. She will use this information to teach Radiologists and residents in Tanzania in order to strive to improve diagnoses to decrease mortality rates from breast cancer.
The Department of Radiology is pleased to announce the following promotions, effective July 1, 2019:
Richard Bruce, MD, to Associate Professor (CHS) – Dr. Bruce joined the faculty in 2009 as both an Assistant Professor of Neuroradiology and the Medical Director of Radiology Informatics. He has received grants for his work in numerous areas of Clinical Decision support and medical informatics. Dr. Bruce earned his MD at the University of Texas – Southwestern Medical School in Dallas, and completed both his residency and neuroradiology fellowship at the University of Wisconsin–Madison.
Samuel Charles, MD, to Clinical Professor (CT) – Dr. Charles joined the faculty in 2007 asClinical Assistant Professor. He has served as the Associate Chief of Operations for the Community Division of the Department of Radiology. He became a Clinical Associate Professor in 2014. Dr. Charles completed both his residency and fellowship in musculoskeletal imaging at the University of Wisconsin–Madison.
Peter Chase, MD, to Clinical Professor (CT) – Dr. Chase became a faculty member in 2007 as a Clinical Assistant Professor, and also served as CT Modality Chief and Associate Chief of Outreach. He became a Clinical Associate Professor in 2014. Dr. Chase completed his residency and abdominal imaging fellowship at the University of Wisconsin–Madison.
Mai Elezaby, MD, to Associate Professor (CHS) – Dr. Elezaby joined the UW Department of Radiology faculty in 2012, after completing her residency, honorary fellowship and fellowship in breast imaging at the University of Wisconsin–Madison. She has served both as Associate Program Director of the Radiology Residency Program, as well as the Director of the Online Learning Center.
Carolyn Haerr, MD, to Clinical Professor (CT) – Dr. Haerr became a faculty member in 2002, as a Clinical Assistant Professor. She completed residencies in both pediatric radiology and diagnostic radiology at the University of Colorado Health Sciences Center, and Presbyterian/St. Luke’s Hospital in Denver, respectively. Dr. Haerr completed a musculoskeletal radiology fellowship at the Mallinckrodt Institute of Radiology in St. Louis, MO. She has served in the Department as the Lead Interpreting Radiologist for Meriter Mammography Clinic and the Modality Chief of MSK for the Community Radiology Division.
Newrhee Kim, MD, to Clinical Professor (CT) – Dr. Kim joined the faculty as a Clinical Assistant Professor in 2007. He completed his residency at Winthrop University Hospital, Mineola, NY, and a fellowship in diagnostic neuroradiology at the UW–Madison School of Medicine and Public Health. Dr. Kim has also serves as Vice Chair/Section Chief of the Community Radiology Division.
Kenneth Lee, MD, to Professor (CHS) – Dr. Lee joined the UW Department of Radiology faculty in 2008 as Assistant Professor. He completed his residency at Henry Ford Hospital in Detroit, MI, and his musculoskeletal fellowship at the UW–Madison School of Medicine and Public Health. Dr. Lee has also served as the Medical Director for Clinical Musculoskeletal Ultrasound, Director of Ultrasound Research and the Medical Director of WIMR Translational Imaging.
Tyler Prout, MD, to Clinical Professor (CT)– Dr. Prout joined the Department faculty as Clinical Assistant Professor in 2007. He completed both his residency and abdominal imaging fellowship at the UW School of Medicine and Public Health. Dr. Prout was active in the United States Navy where he was a US Naval Flight Surgeon at the Great Lakes Reserve Fleet Hospital, Great Lakes, IL. He also received his Lean Six Sigma Yellow Belt Certification at the UW–Madison School of Business. He has served as the Modality Chief of Ultrasound in the Community Section and as the Associate Vice Chair of Quality and Safety.
Jason Stephenson, MD, to Associate Professor (CHS) – Dr. Stephenson became a member of the Department of Radiology faculty in 2012. He completed both his residency and fellowship in musculoskeletal radiology at the Mallinckrodt Institute of Radiology, Barnes-Jewish Hospital, in St. Louis, MO. Dr. Stephenson is currently serving as the Director of Medical Student Education in the department, and as the Integrated Block Leader for the Mind & Motion Course in the Department of Medical Education.
Tim Szczykutowicz, PhD, to Associate Professor (CHS)– Dr. Szczykutowicz became a Department of Radiology faculty member in 2014, as an Assistant Professor. He earned his Master of Science on Medical Physics at the UW–Madison, and his PhD in Medical Physics studying under Professors Charles Mistretta and Guang-Hong Chen. He received his certification by the American Board of Radiology in Diagnostic Medical Physics in 2016.
The Department also has made the following appointments, effective July 1, 2019:
Jane Lyon, MD, to Clinical Associate Professor (CT) – Dr. Lyon joined the UW Department of Radiology faculty in 2017 as a Pediatric Radiologist. She completed her residency at the UMDNJ Cooper University Medical Center in Camden, NJ and completed her fellowship in pediatric radiology at the Children’s Hospital of Philadelphia. Dr. Lyon has served as the Modality Chief, Pediatric/Fetal MRI and the Chief of Pediatric Medical Student Education.
Joseph Tang, MD, to Clinical Associate Professor (CT) – Dr. Tang became a Department of Radiology faculty member in 2018, as a Visiting Clinical Associate Professor of Radiology in the Musculoskeletal Imaging and Intervention Section. He completed his residency at the University of Washington in Seattle, and his fellowship in Musculoskeletal Imaging at the UW School of Medicine and Public Health.
The Department of Radiology congratulates our remarkable colleagues for their hard work and great accomplishments on this momentous occasion!
Thomas Grist, MD, Chair of the UWSMPH Department of Radiology, recently announced new department leadership changes that took effect on July 1.Dr. Grist noted that as department sections become larger, the Section Chief duties become more complex which involves clinical care, oversight of research programs as well as oversight of Fellowship programs. Please join the department in congratulating the following faculty for supporting our mission to improve human health through innovation in clinical care, imaging research and education as well as administratively managing their sections:
Tabby Kennedy, MD – Section Chief of Neuroradiology
Dr. Kennedy will be replacing Dr. Aaron Field after 7 years in this role. Dr. Field has requested to step down and focus more on his research activities. Dr. JP Yu will replace Dr. Kennedy as the Neuroradiology Fellowship Director. Dr. Greg Avey will assume the role of Director of Heck & Neck Imaging.
Steve Cho, MD – Associate Section Chief of Nuclear Medicine and Molecular ImagingNuclear Medicine has become more complex due to the expansion of the new Radio-Pharmaceutical Production Facility (RPF), development of a new Theranostics program, and with the advent of new tracers and imaging procedures. Dr. Cho will take on his new to help lead the many changes in the section of Nuclear Medicine and Molecular imaging. Importantly, Dr. Cho recently helped lead an important site visit to become an FDA-approved site to produced novel radiopharmaceutical tracers.
Mark Kleedehn, MD –Interventional Radiology (IR) Fellowship DirectorWith a host of new initiatives surrounding the newly approved IR Fellowship, Dr. Kleedehn agreed to take on the role of IR fellowship Director. He will be collaborating with the Diagnostic Radiology (DR) Residency Leadership team to streamline the transition process.
Ken Lee, MD – Associate Section Chief- Clinical and Diagnostic Operations, Musculoskeletal Imaging and Interventions
In this role, Dr. Lee will serve as Section Chief in Dr. Davis’ absence, assess workflow and clinical rotations, and provide strategic vision and program development in collaboration with the Section Chief to address any changes to the MSK clinical, research or teaching efforts. He will assume oversight of some of the clinical operations as well.
Tito Rosas, MD –Associate Section Chief-Interventional Procedures Musculoskeletal Imaging and Intervention
Dr. Rosas will continue to oversee all musculoskeletal interventional programs. He will assess and evaluate the need for expanding procedures. He will evaluate new MSK procedures and schedule training, including in-services for technologists, fellows, and residents; and adjust schedule templates to accommodate these changes. He will interface with other clinical departments to educate them on our capabilities and to understand their needs for musculoskeletal interventions.
Rick Kijowski, MD – Director of Musculoskeletal Imaging and Intervention Research Program
Dr. Kijowski will oversee the MSK Section research efforts, with input from the section members regarding their ongoing research efforts and plans, assess for opportunities, and plan for projects. He will be the section’s representative to the Department R&D Committee and oversee MSK interactions with WIMR staff and interdepartmental collaborations. As the Department’s research enterprise continues to evolve and expand, Dr. Kijowski will represent the MSK Section in all discussions and planning.
Please join us in congratulating these individual on their new leadership roles!
When Wisconsin’s first patient was treated last year with a newly introduced drug therapy for a neuroendocrine tumor (NET), it truly took a village to make the treatment become a reality. UW Hospital clinicians and staff from the Nuclear Medicine and Molecular Imaging Section of the Department of Radiology and the Department of Medicine’s Division of Hematology, Medical Oncology and Palliative Care, plus hospital safety experts and pharmacists, all worked together to be able to make the radioactive, tumor-specific drug treatment available to treat patients in record time.
Steve Cho, MD, Nuclear Medicine and Molecular Imaging Faculty member, Director of the UW Radiopharmaceutical Production Facility and Associate Director of the UW PET Imaging Center, remembers the great effort behind the orchestration. “Our clinicians and techs played a critical role in getting the proper treatment to the patient very quickly,” he said. “At that time, there was a lot of public interest in this new drug treatment available in the United States, as it was previously only available in Europe.”
NETs of the gastrointestinal tract arise from specialized cells called neuroendocrine cells. They represent only about a half of one percent of newly diagnosed cancers. “There is a very low incidence for these types of cancer,” Cho said, “they are also very slow-growing, and people can live with them for a long time so there is actually a high prevalence or number of patients with this cancer. They can be widely metastatic,” he said. After a while, the current treatment used becomes less effective, and the majority of patients do not survive the disease.
The new drug, Lutetium-177 dotatate (marketed as Lutathera®), showed in clinical trials that it stopped the growth of 65 percent of patient’s tumors after treatment, as compared with 11 percent whose tumors stopped growing that instead received a higher dose of common NET therapy. With those who received the revolutionary Lutathera treatment, 18 percent of the patient’s tumors actually shrank. “Lutathera treatment showed markedly longer survival rates for NET patients,” Cho said. “It was a game-changer, and showed much more dramatic results than people anticipated.”
Lutathera was approved by the FDA for use in the US on January 28, 2018, and calls to UW Hospital from NET patients started flowing in right away. Physicians and staff in both Nuclear Medicine and Oncology acted immediately. Dr. Cho and Scott Perlman, MD, MS, Director of the UW PET Imaging Center, and Section Chief of UW Nuclear Medicine and Molecular Imaging, and Scott Knishka, RPh, BCNP, Nuclear Pharmacy Manager, orchestrated the Nuclear Medicine effort. “Collaborating closely with the Carbone Cancer Center, including the patient’s oncologist, Noelle LoConte, and medical oncologists Sam Lubner and Dan Mulkerin, we began the process of developing the treatment protocol,” Cho said. According to Dr. Perlman, one of the first obstacles we faced was where to administer the intravenous treatment. “This led to our team searching around the hospital complex for an adequate space to administer the therapy. This is where we were fortunate to meet Kendra O’Connell, RN, the Carbone Cancer Center clinic manager who was willing to allow us to use a room a few days a week along with nursing support, even though their clinic was already very busy. This was a huge help and really allowed us to move forward rapidly,” said Dr. Perlman.
“We had to immediately focus on the many different elements that needed to be completed,” Dr. Perlman continued. “We had to complete all the paperwork – protocol consent form, written directives, get P & T and Human Radiation Use Committees approvals, engage radiation safety – everything, as it was a brand-new drug,” he said. Much of this was coordinated by Mr. Knishka, who coordinated the development of the protocols, written directives, the consent form, and other paperwork required to get the drug approved within Radiology and UW Hospital.
The Nuclear Medicine team learned that the commercial FDA approved amino acid solutions used as a radioprotectant induced acute nausea. The Nuclear Medicine physician now prescribes a custom compounded amino solution that reduces this side effect. This has lead to a better patient experience.The procurement of the radiopharmaceutical and the radioproctectant is coordinated by Angel Kubly, RPh, in the nuclear pharmacy.
As a result of the UW Department of Radiology’s Nuclear Medicine and Molecular Imaging excellent work, the UW Hospital became the first facility in the state and the 20th in the nation to administer this specific cancer therapy. “During the treatment, nuclear medicine physicians and techs were there the whole time, and oversaw everything,” Dr. Perlman said. “We have successfully managed the side effects and are now treating one or two patients per week with Lutathera. People are still calling to schedule treatment, and those we are treating rave about being able to receive the Lutathera right here in Wisconsin,” he said. According to Dr. Perlman, the demand has been so high there is currently about a five month wait for patients to be treated.
“Treating and imaging using the same target therapy is known as ‘theranostics,’ combining molecular imaging and targeted radionuclide therapy (TRT),” Dr. Cho said. “We expect this treatment to be the first of many new theranostic therapies to become available. It is the ideal example of personalized and precision medicine,” Cho said. “Theranostics is the future of nuclear medicine.”
The Nuclear Medicine Section would like to also recognize the expert assistance of the Nuclear Medicine Manager Derek Fuerbringer, CNMT, nuclear medicine technologists Rosalie Hovey-Andersen and Dani Brunk, and the radiation safety team headed by Jason Timm, Radiation Safety Officer, to make this feat become a reality. Lutathera is manufactured by Advanced Accelerator Applications.
UW School of Medicine and Public Health Department of Radiology faculty members Mark Kliewer, MD and Lori Mankowski-Gettle, MD, and department Student Services Coordinator, Katie Yang, MS, will be collaborating with Dr. C. Shawn Green from the Department of Psychology on a project funded by the RSNA Research and Education Foundation. This RSNA Education Development Grant for Patient Education will fund a project that examines the patient consent process. Very little is known about what rhetorical strategies are best for framing risk during the consent process, and even less is known of how this impacts how the patient perceives the procedure in terms of anxiety, confidence in the procedure, and even pain experienced during the procedure. This project will address this gap in knowledge by 1) recording and identifying the key elements of risk explanation during the patient consent process and 2) testing scripts in which risk is framed differently. It is their goal to produce knowledge and educational content on what the best practices are for talking about risk during the consent process. The project will run from 2019 – 2021, and it has been awarded $165,077.
Scientists and researchers around the world are reaching an entirely new level of discovery with Artificial Intelligence (AI), using data to solve problems and enabling decisions in innovative new ways. AI remains a dominant conversation at scientific symposia across the globe and once again received top billing at RSNA and ISMRM annual meetings. One need not travel far to see how AI is creating new frontiers – it is also a big part of the research being conducted at the University of Wisconsin Department of Radiology.
The term AI dates back to the 1950s, but its present state is possible through the development of supercomputers. Advances in computer hardware over the past decade have paved the way for very complex algorithms to run quickly and easily, producing data faster than we could ever have imagined before. The Department has made the commitment to create a robust technical infrastructure to support innovation and encourage the expansion of AI in Radiology here at UW. Our Director of Informatics, John Garrett, PhD, is currently focusing on developing the infrastructure to support faculty and provide access to the type of equipment needed to process the large amounts of data necessary for Deep Learning (DL), a subset of AI.
The department invested in a GPU supercomputer, a networked group of computers whose processing power far surpasses the capabilities of even the most powerful CPU. “These are the same computers used in gaming applications,” Garrett said. “The power of the GPU processing is equivalent to a whole server farm – this is the type of computer we want to get people used to using to be able to do things they simply can’t on other computers,” he said.
Dr. Garrett noted that there are challenges to incorporating AI into a traditional hospital network, and to be able to integrate it into the clinical workflow. That is where many of the department faculty are closing the gap.
Vivek Prabhakaran, MD, PhD, is Department of Radiology faculty member who is using AI to make new discoveries. He has led the efforts to train an AI model using MRI input to create synthetic FDG PET images. Traditional FDG PET scans are currently the standard for understanding brain metabolism and diagnosing Alzheimer’s disease. They involve the injection of a radioactive tracer, fluorodeoxyglucose, or FDG, into the patient before the PET scan, to show the differences between the healthy and diseased tissue in the brain. Dr. Prabhakaran’s synthetic version using MRI involves no radiation and had a 97 percent correlation rate with the test that used radiation. “Not only is this new method non-invasive, without the injection of radioactive tracers, but it can be done at a much lower cost,” Dr. Prabhakaran said. The AI algorithm used by Prabhakaran has great potential to be expanded to other uses, for example to help diagnose cancer, epilepsy and myocardial viability.
Alan McMillan, PhD, director of the Molecular Imaging / Magnetic Resonance Technology Lab (MIMRTL) is one of “superusers” of the NVIDIA® DGX™ supercomputer system, seeking ways to advance MRI, PET/MR and PET/CT imaging techniques. “There is no aspect of our research that doesn’t incorporate AI,” McMillan said. In fact, he sees the rapid growth of AI as a boon to all future research, allowing machines to focus on the algorithms and enabling people to focus on the more physical aspects of human health. Some of McMillan’s recent efforts have centered on finding a way to create CT-like imaging from MRI images. Using Deep Learning, Dr. McMillan’s team has been able to reconstruct robust CT images directly from clinical MR images. When these images are used to perform attenuation correction, they enable more quantitatively accurate PET images for simultaneous PET/MR and reduce error from 10-25% (in conventional techniques) to less than 5%.
Another researcher and clinician who is tapping into AI to discover new information is Perry Pickhardt, MD. Dr. Pickhardt recently found a new way to obtain additional “opportunistic” diagnostic information about the structures seen in the abdomen during abdominal Computed Tomography (CT) imagery performed during CT colonography. “CT sees many things,” Dr. Pickhardt said. “We wanted to take the extra biomarkers in the CT scans and try to do something more with them. A CT scan also has information about patients’ bone, muscle, fat, calcium, and more,” Pickhardt continued.“With this, we can get a read on many other important health connotations, for example, we can quantify the aortic calcium levels of a patient and make a prediction about his or her likelihood of a cardiac event.” Dr. Pickhardt’s paper, “Fully-Automated Analysis of Abdominal CT Scans for Opportunistic Prediction of Cardiometabolic Events: Initial Results in a Large Asymptomatic Adult Cohort,” received the Roscoe E. Miller Best Paper Award at the recent Society of Abdominal Radiology (SAR) conference.
Vivek Prabhakaran, MD, PhD, is another Department of Radiology faculty member who is using AI to make new discoveries. He has led the efforts to train an AI model using MRI input to create synthetic FDG PET images. Traditional FDG PET scans are currently the standard for understanding brain metabolism and diagnosing Alzheimer’s disease. They involve the injection of a radioactive tracer, fluorodeoxyglucose, or FDG, into the patient before the PET scan, to show the differences between the healthy and diseased tissue in the brain. Dr. Prabhakaran’s synthetic version using MRI involves no radiation and had a 97 percent correlation rate with the test that used radiation. “Not only is this new method non-invasive, without the injection of radioactive tracers, but it can be done at a much lower cost,” Dr. Prabhakaran said. The AI algorithm used by Prabhakaran has great potential to be expanded to other uses, for example to help diagnose cancer, epilepsy and myocardial viability.
Innovations made possible by AI are occurring in practically every area of the imaging world. Department of Radiology researchers Richard Kijowski, MD, and Fang Liu, PhD, have developed a fully automated deep-learning system that uses two deep convolutional neural networks to detect anterior cruciate ligament ears (ACL) tears on knee MRI exams.The result of their research showed that a fully automated deep learning network could determine the presence or absence of ACL tears with similar diagnostic performance as experienced musculoskeletal radiologists.Similar deep learning algorithm have been developed by Drs. Kijowski and Liu to detect other musculoskeletal pathology, including cartilage lesions on MRI and hip fractures on pelvic radiographs. The use of deep learning methods to detect musculoskeletal pathology could provide immediate preliminary interpretations of imaging studies, maximize diagnostic performance, and reduce errors due to distraction and fatigue. “However, future work is needed for further technical development and validation before this could be implemented into clinical practice,” said Dr. Kijowski. “I look forward to the future of this research.”
The evolution of AI is currently thriving across UW campus, and is especially evident in the Department of Radiology. But many are wondering, what should we expect from the future of AI? “My hope for AI is that it will create a better use for people’s intelligence,” Dr. McMillan said. “We can decide what problems are most important, and use AI to solve problems in faster and better ways. For many scientists, AI need not be the focus of their research, rather it can be leveraged as a tool that enables us to solve problems that couldn’t easily be solved in any other way,” he said. “The hope for the future is that we will keep finding more hard problems for AI to solve more quickly and efficiently. It is truly humbling and exciting work.”
Department of Radiology MRI/MBA Fellow Liisa Bergmann, MD, was recently selected to receive an ACGME Back to Bedside grant. This initiative is intended to directly support residents and fellows as they lead projects that increase patient engagement and shape clinical learning environments in a meaningful manner.
Dr. Bergmann’s work focuses on patient access to radiologists after cardiac imaging exams. Historically, radiology results have been communicated to patients via the referring doctor who ordered the imaging. Less than one year ago, UW Health patients were provided with their full radiology reports online via the electronic medical record, without the counsel of any physician. Radiologists providing “direct-to-patient reporting” goes beyond this to help alleviate patient anxiety from having access to a very technical, scientific report that is written for other physicians. Patients who have undergone cardiac imaging have the option to meet with the radiologist personally, to enhance their comprehension of the information by walking through the report and images of their own anatomy.
Dr. Bergmann is excited to be recognized by the ACGME for her project. “There is a trend toward increased patient interaction across all of radiology,” Dr. Bergmann said. “I hope this project will be an exciting form of health science education for curious patients.”